FlavioG.VincentiMD

Clinical Trials

• Study of ISA247 (Voclosporin) in De Novo Renal Transplantation Start of enrollment: 2006 Jan 01

  Completed

  Phase 2

• Belatacept to Prevent Organ Rejection in Kidney Transplant Patients Start of enrollment: 2006 Dec 01

  Terminated

  Phase 2

• The Effect of Rituximab on the Development of Anti-Donor Antibodies Start of enrollment: 2004 Aug 01

  Completed

  Not Applicable

• Pilot Trial to Assess Effect of CNI Conversion of Efalizumab on T Reg Cells Start of enrollment: 2008 Dec 01

  Withdrawn

  Phase 1, Phase 2

• NFAT-Dependent Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Patients Start of enrollment: 2013 May 02

  Completed

  Not Applicable

• Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation Start of enrollment: 2013 Nov 01

  Terminated

  Phase 2

• Treg Adoptive Therapy for Subclinical Inflammation in Kidney Transplantation Start of enrollment: 2014 Mar 01

  Completed

  Phase 1

• Tocilizumab for Renal Graft Inflammation Start of enrollment: 2014 Jun 01

  Completed

  Phase 2

• Precision Medicine Offers Belatacept Monotherapy Start of enrollment: 2019 Feb 01

  Withdrawn

  Phase 4

• Immune Monitoring in Sensitized Patients at Risk of Rejection Start of enrollment: 2015 Aug 20

  Completed

• Treg Modulation With CD28 and IL-6 Receptor Antagonists Start of enrollment: 2019 Dec 11

  Completed

  Phase 1, Phase 2

• Join now to see all